Fluid Resuscitation and Progression to Renal Replacement Therapy in Patients With COVID-19
- PMID: 35045940
- PMCID: PMC8552546
- DOI: 10.1016/j.jemermed.2021.10.026
Fluid Resuscitation and Progression to Renal Replacement Therapy in Patients With COVID-19
Abstract
Background: Coronavirus disease 2019 (COVID-19) is associated with respiratory symptoms and renal effects. Data regarding fluid resuscitation and kidney injury in COVID-19 are lacking, and understanding this relationship is critical.
Objectives: To determine if there is an association between fluid volume administered in 24 h and development of renal failure in COVID-19 patients.
Methods: Retrospective chart review; 14 hospitals in Indiana. Included patients were adults admitted between March 11, 2020 and April 13, 2020 with a positive test for severe acute respiratory syndrome coronavirus 2 within 3 days of admission. Patients requiring renal replacement therapy prior to admission were excluded. Volumes and types of resuscitative intravenous fluids in the first 24 h were obtained with demographics, medical history, and other objective data. The primary outcome was initiation of renal replacement therapy. Logistic regression modeling was utilized in creating multivariate models for determining factors associated with the primary outcome.
Results: The fluid volume received in the first 24 h after hospital admission was associated with initiation of renal replacement therapy in two different multivariate logistic regression models. An odds ratio of 1.42 (95% confidence interval 1.01-1.99) was observed when adjusting for age, heart failure, obesity, creatinine, bicarbonate, and total fluid volume. An odds ratio of 1.45 (95% confidence interval 1.02-2.05) was observed when variables significant in univariate analysis were adjusted for.
Conclusions: Each liter of intravenous fluid administered to patients with COVID-19 in the first 24 h of presentation was independently associated with an increased risk for initiation of renal replacement therapy, supporting judicious fluid administration in patients with this disease.
Keywords: COVID-19; acute kidney injury; coronavirus; hemodialysis; renal replacement therapy; resuscitation.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.Am J Nephrol. 2020;51(10):786-796. doi: 10.1159/000511160. Epub 2020 Oct 2. Am J Nephrol. 2020. PMID: 33011717 Free PMC article.
-
Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.Blood Purif. 2021;50(4-5):520-530. doi: 10.1159/000513425. Epub 2020 Dec 18. Blood Purif. 2021. PMID: 33341806 Free PMC article.
-
Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.Trials. 2020 Nov 11;21(1):920. doi: 10.1186/s13063-020-04814-0. Trials. 2020. PMID: 33176886 Free PMC article.
-
The relationship of intravenous fluid chloride content to kidney function in patients with severe sepsis or septic shock.Am J Emerg Med. 2015 Mar;33(3):439-43. doi: 10.1016/j.ajem.2014.12.013. Epub 2014 Dec 18. Am J Emerg Med. 2015. PMID: 25650359
-
Fluid overload and acute kidney injury.Hemodial Int. 2010 Oct;14(4):348-54. doi: 10.1111/j.1542-4758.2010.00498.x. Hemodial Int. 2010. PMID: 20955269 Review.
Cited by
-
Oxidized High-Density Lipoprotein Induces Endothelial Fibrosis Promoting Hyperpermeability, Hypotension, and Increased Mortality.Antioxidants (Basel). 2022 Dec 15;11(12):2469. doi: 10.3390/antiox11122469. Antioxidants (Basel). 2022. PMID: 36552677 Free PMC article.
-
Clinical characteristics and prognosis of patients with COVID-19 on mechanical ventilation undergoing continuous renal replacement therapy.PLoS One. 2024 Apr 3;19(4):e0297344. doi: 10.1371/journal.pone.0297344. eCollection 2024. PLoS One. 2024. PMID: 38568934 Free PMC article.
-
Changing epidemiology of acute kidney injury in critically ill patients with COVID-19: a prospective cohort.Ann Intensive Care. 2022 Dec 28;12(1):118. doi: 10.1186/s13613-022-01094-6. Ann Intensive Care. 2022. PMID: 36575315 Free PMC article.
-
[Expert consensus on the clinical treatment of burn patients complicated with Coronavirus infection (2023 version)].Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 Aug 20;39(8):701-712. doi: 10.3760/cma.j.cn501225-20230519-00176. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023. PMID: 37805779 Free PMC article. Chinese.
References
-
- World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/. Accessed April 4, 2021.
-
- Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. JAMA. 2020;323:1839–1841. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous